Marcus Flather - Researcher Profile | RDL Research Database

Publications

3 shown

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lars Wallentin , Salim Yusuf , Michael D. Ezekowitz +11 more

2010 The Lancet 1003 citations

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

John H. Alexander , Renato D. Lópes , Stefan James +31 more

The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding ev...

2011 New England Journal of Medicine 990 citations

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker , Giulia Renda , Tom Thurén +25 more

Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent ...

2017 New England Journal of Medicine 8436 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 10,429
Institution: Royal Brompton Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5644-3116

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.